Bilaketaren emaitzak - Marie‐Odile Joly
- Erakusten 1 - 4 emaitzak -- 4
-
1
Gemcitabine and oxaliplatin or alkylating agents for neuroendocrine tumors: Comparison of efficacy and search for predictive factors guiding treatment choice nork Anne‐Sophie Dussol, Marie‐Odile Joly, Cécile Vercherat, Julien Forestier, Valérie Hervieu, Jean‐Yves Scoazec, Catherine Lombard‐Bohas, Thomas Walter
Argitaratua 2015Artigo -
2
-
3
Characteristics of H3 K27M-mutant gliomas in adults nork David Meyronet, Maud Esteban-Mader, Charlotte Bonnet, Marie‐Odile Joly, Emmanuelle Uro‐Coste, Alexandra Amiel‐Benouaich, Fabien Forest, Cécilia Rousselot-Denis, Fanny Burel‐Vandenbos, Véronique Bourg, Jacques Guyotat, Tanguy Fenouil, Anne Jouvet, Jérôme Honnorat, François Ducray
Argitaratua 2016Artigo -
4
Validation of the high-performance of pyrosequencing for clinical <i>MGMT</i> testing on a cohort of glioblastoma patients from a prospective dedicated multicentric trial nork Véronique Quillien, Audrey Lavenu, François Ducray, Marie‐Odile Joly, Olivier Chinot, Frédéric Fina, Marc Sanson, Alain Carpentier, Lucie Karayan‐Tapon, Pierre Rivet, Natacha Entz‐Werlé, M Legrain, Emmanuèle Lechapt Zalcman, Guénaëlle Levallet, Fabienne Escande, Carole Ramirez, Dan Christian Chiforeanu, Élodie Vauléon, Dominique Figarella‐Branger
Argitaratua 2016Artigo
Bilaketa egiteko lanabesak:
Antzeko gaiak
Biology
Cancer research
Genetics
Internal medicine
Medicine
Cancer
Colorectal cancer
Gene
Oncology
Pathology
Temozolomide
Astrocytoma
Axon guidance
Biochemistry
Brainstem
Carcinogenesis
Cell biology
Cerebellum
Chemistry
Chemotherapy
Chromatography
Dacarbazine
Deleted in Colorectal Cancer
Enzyme
Epilepsy
Ganglioglioma
Gemcitabine
Glioblastoma
Glioma
Histone